Insider Stock Trading History of Baker Mark Robert


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Baker Mark Robert since year 2005. The trader's CIK number is 1331438. At the time of this reporting, Baker Mark Robert is the General Counsel of Progenics Pharmaceuticals Inc . (stock ticker symbol PGNX). See this page for all insider trading activities at Progenics Pharmaceuticals Inc .


Stock purchases, sales, and option exercises reported by insider Baker Mark Robert since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2013-03-27 PGNX Progenics Pharmaceuticals Inc Buy 650 5.34 3,469
2013-01-22 PGNX Progenics Pharmaceuticals Inc Buy 1,215 2.82 3,432
2012-12-26 PGNX Progenics Pharmaceuticals Inc Buy 1,142 3.01 3,437
2012-11-28 PGNX Progenics Pharmaceuticals Inc Buy 1,607 2.13 3,419
2012-11-19 PGNX Progenics Pharmaceuticals Inc Buy 11,800 1.96 23,104
2012-11-16 PGNX Progenics Pharmaceuticals Inc Buy 49,793 1.82 90,722
2012-11-15 PGNX Progenics Pharmaceuticals Inc Buy 48,833 1.69 82,332
2012-10-24 PGNX Progenics Pharmaceuticals Inc Buy 1,162 2.96 3,433
2012-09-26 PGNX Progenics Pharmaceuticals Inc Buy 1,036 3.32 3,439
2012-08-22 PGNX Progenics Pharmaceuticals Inc Buy 815 4.23 3,450
2012-07-25 PGNX Progenics Pharmaceuticals Inc Buy 346 10.04 3,472
2012-06-27 PGNX Progenics Pharmaceuticals Inc Buy 375 9.26 3,474
2012-05-23 PGNX Progenics Pharmaceuticals Inc Buy 445 7.81 3,475
2012-04-25 PGNX Progenics Pharmaceuticals Inc Buy 348 10.10 3,514
2012-03-28 PGNX Progenics Pharmaceuticals Inc Buy 343 10.12 3,472
2012-02-22 PGNX Progenics Pharmaceuticals Inc Buy 369 9.44 3,484
2012-01-25 PGNX Progenics Pharmaceuticals Inc Buy 364 9.50 3,458
2012-01-11 PGNX Progenics Pharmaceuticals Inc Buy 391 8.86 3,466
2011-10-26 PGNX Progenics Pharmaceuticals Inc Buy 532 6.52 3,467
2011-11-23 PGNX Progenics Pharmaceuticals Inc Sale 634 5.45 3,455
2011-10-03 PGNX Progenics Pharmaceuticals Inc Option Ex 5,124 4.62 23,693
2011-09-28 PGNX Progenics Pharmaceuticals Inc Buy 542 6.38 3,460
2011-08-24 PGNX Progenics Pharmaceuticals Inc Buy 571 6.08 3,471
2011-07-27 PGNX Progenics Pharmaceuticals Inc Buy 567 6.12 3,471
2011-07-01 PGNX Progenics Pharmaceuticals Inc Option Ex 20,032 5.46 109,374
2011-06-22 PGNX Progenics Pharmaceuticals Inc Buy 490 7.08 3,469
2011-05-25 PGNX Progenics Pharmaceuticals Inc Buy 486 7.13 3,465
2011-04-27 PGNX Progenics Pharmaceuticals Inc Buy 479 7.24 3,467
2011-04-01 PGNX Progenics Pharmaceuticals Inc Option Ex 4,022 5.05 20,311
2011-01-03 PGNX Progenics Pharmaceuticals Inc Option Ex 4,377 4.83 21,132
2010-10-01 PGNX Progenics Pharmaceuticals Inc Option Ex 17,545 4.32 75,759
2010-07-01 PGNX Progenics Pharmaceuticals Inc Option Ex 4,575 4.44 20,313
2010-06-22 PGNX Progenics Pharmaceuticals Inc Sale 2,328 5.66 13,185
2010-04-01 PGNX Progenics Pharmaceuticals Inc Option Ex 4,300 4.56 19,590
2010-03-18 PGNX Progenics Pharmaceuticals Inc Sale 2,165 5.33 11,539
2010-01-04 PGNX Progenics Pharmaceuticals Inc Option Ex 4,720 3.78 17,855
2009-10-01 PGNX Progenics Pharmaceuticals Inc Option Ex 3,999 4.26 17,031
2009-07-01 PGNX Progenics Pharmaceuticals Inc Option Ex 13,207 5.33 70,393
2009-04-01 PGNX Progenics Pharmaceuticals Inc Option Ex 3,180 5.65 17,967
2009-01-02 PGNX Progenics Pharmaceuticals Inc Option Ex 2,033 9.13 18,561
2008-10-01 PGNX Progenics Pharmaceuticals Inc Option Ex 2,393 6.53 15,626
2008-10-01 PGNX Progenics Pharmaceuticals Inc Option Ex 2,393 6.53 15,626
2008-07-01 PGNX Progenics Pharmaceuticals Inc Option Ex 4,865 13.64 66,358
2008-04-01 PGNX Progenics Pharmaceuticals Inc Option Ex 2,533 6.52 16,515
2008-01-02 PGNX Progenics Pharmaceuticals Inc Option Ex 916 15.33 14,042
2007-10-01 PGNX Progenics Pharmaceuticals Inc Option Ex 748 19.03 14,234
2007-10-01 PGNX Progenics Pharmaceuticals Inc Option Ex 748 19.03 14,234
2007-07-02 PGNX Progenics Pharmaceuticals Inc Option Ex 3,451 18.71 64,568
2007-04-02 PGNX Progenics Pharmaceuticals Inc Option Ex 621 20.13 12,500
2007-01-03 PGNX Progenics Pharmaceuticals Inc Option Ex 571 21.88 12,493
2006-10-02 PGNX Progenics Pharmaceuticals Inc Option Ex 627 19.58 12,276
2006-07-03 PGNX Progenics Pharmaceuticals Inc Option Ex 3,056 25.01 76,430
2006-04-03 PGNX Progenics Pharmaceuticals Inc Option Ex 500 21.77 10,884
2006-01-03 PGNX Progenics Pharmaceuticals Inc Option Ex 539 20.86 11,243

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Baker Mark Robert (General Counsel of Progenics Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.